Advanced search
1 file | 2.98 MB Add to list

SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization

Nele Festjens (UGent) , Kristof Vandewalle (UGent) , Erica Houthuys (UGent) , Evelyn Plets (UGent) , Dieter Vanderschaeghe (UGent) , Katlyn Borgers (UGent) , Annelies Van Hecke (UGent) , Petra Tiels (UGent) and Nico Callewaert (UGent)
(2019) VACCINE. 37(27). p.3539-3551
Author
Organization
Keywords
Tuberculosis, Vaccine, SapM, Immunomodulation, GUINEA-PIG MODEL, MYCOBACTERIUM-TUBERCULOSIS, PROTECTIVE IMMUNITY, IN-VITRO, METAANALYSIS, MENINGITIS, CHALLENGE, RESPONSES, EFFICACY, STRAINS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.98 MB

Citation

Please use this url to cite or link to this publication:

MLA
Festjens, Nele et al. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” VACCINE 37.27 (2019): 3539–3551. Print.
APA
Festjens, N., Vandewalle, K., Houthuys, E., Plets, E., Vanderschaeghe, D., Borgers, K., Van Hecke, A., et al. (2019). SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization. VACCINE, 37(27), 3539–3551.
Chicago author-date
Festjens, Nele, Kristof Vandewalle, Erica Houthuys, Evelyn Plets, Dieter Vanderschaeghe, Katlyn Borgers, Annelies Van Hecke, Petra Tiels, and Nico Callewaert. 2019. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” Vaccine 37 (27): 3539–3551.
Chicago author-date (all authors)
Festjens, Nele, Kristof Vandewalle, Erica Houthuys, Evelyn Plets, Dieter Vanderschaeghe, Katlyn Borgers, Annelies Van Hecke, Petra Tiels, and Nico Callewaert. 2019. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” Vaccine 37 (27): 3539–3551.
Vancouver
1.
Festjens N, Vandewalle K, Houthuys E, Plets E, Vanderschaeghe D, Borgers K, et al. SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization. VACCINE. 2019;37(27):3539–51.
IEEE
[1]
N. Festjens et al., “SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization,” VACCINE, vol. 37, no. 27, pp. 3539–3551, 2019.
@article{8619697,
  author       = {Festjens, Nele and Vandewalle, Kristof and Houthuys, Erica and Plets, Evelyn and Vanderschaeghe, Dieter and Borgers, Katlyn and Van Hecke, Annelies and Tiels, Petra and Callewaert, Nico},
  issn         = {0264-410X},
  journal      = {VACCINE},
  keywords     = {Tuberculosis,Vaccine,SapM,Immunomodulation,GUINEA-PIG MODEL,MYCOBACTERIUM-TUBERCULOSIS,PROTECTIVE IMMUNITY,IN-VITRO,METAANALYSIS,MENINGITIS,CHALLENGE,RESPONSES,EFFICACY,STRAINS},
  language     = {eng},
  number       = {27},
  pages        = {3539--3551},
  title        = {SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization},
  url          = {http://dx.doi.org/10.1016/j.vaccine.2019.05.022},
  volume       = {37},
  year         = {2019},
}

Altmetric
View in Altmetric
Web of Science
Times cited: